Alcon
Alcon manufactures intraocular lenses, which replace the natural lens removed during cataract surgery. It is the second largest division of Swiss group Novartis.
Alcon operates in more than 75 countries, serving 180 markets and employing more than 24,000 people. The Cork centre manufactures AcrySof® intraocular lenses, the most frequently implanted lenses worldwide.
Technologies and processes featured at the Cork site include mould-tool manufacturing, monomer formulation, casting, curing/polymerization, high precision optical measurement and packaging. Approximately 400 employees work at the site.
Financial Data
-
31st Dec 17 Source: CRO
- €46.4 million turnover
-
€1.5 million
profit - 404 employees
-
31st Dec 16 Source: CRO
- €40.9 million turnover
-
€2.6 million
profit - 394 employees
- 4 more years available »
Ranking
By Turnover
(€46.4 million)- 706th in Top Companies
- 73rd in Pharma
By Employees
(404)- 410th in Top Companies
- 40th in Pharma
- 404
- €46.4 million
Employees
- Jackie Murphy Country Manager
Latest News
- 8:17am Airbnb secures $1bn investment from Silver Lake, Sixth Street
- 7:49am Tokyo stocks rise on hopes of coronavirus slowdown
- 7:22am French luxury groups U-turn on state support for jobs
- 6:54am Business activity in Dublin grinds to a seven year low
- 6:54am Business activity in Dublin grinds to a seven-year low due to Covid-19 impact